120017
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.6 Breast Cancer (Dove Med Press)
- 4.3 Clin Epidemiol
- 2.6 Cancer Manag Res
- 3.2 Infect Drug Resist
- 4.1 Clin Interv Aging
- 6.1 Drug Des Dev Ther
- 4.1 Int J Chronic Obstr
- 8.7 Int J Nanomed
- 2.5 Int J Women's Health
- 3.2 Neuropsych Dis Treat
- 2.4 OncoTargets Ther
- 2.6 Patient Prefer Adher
- 2.6 Ther Clin Risk Manag
- 3.1 J Pain Res
- 3.5 Diabet Metab Synd Ob
- 4.5 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 2.4 Pharmgenomics Pers Med
- 2.6 Risk Manag Healthc Policy
- 4.6 J Inflamm Res
- 2.3 Int J Gen Med
- 3.9 J Hepatocell Carcinoma
- 3.3 J Asthma Allergy
- 2.5 Clin Cosmet Investig Dermatol
- 3.0 J Multidiscip Healthc
已发表论文
实时定量 PCR 及循环阈值（Ct）诊断住院患者耶氏肺孢子菌肺炎的性能特征
Authors Cao G, Wang D, Shi X, Ru J, Chen Y, Lu Z
Received 21 November 2025
Accepted for publication 28 January 2026
Published 7 February 2026 Volume 2026:19 577623
DOI https://doi.org/10.2147/IDR.S577623
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Hazrat Bilal
Guomei Cao, Dan Wang, Xiaodi Shi, Jincheng Ru, Yafang Chen, Zhiyong Lu
Department of Clinical Laboratory, Shaoxing University Affiliated Central Hospital, Shaoxing, Zhejiang, People’s Republic of China
Correspondence: Zhiyong Lu, Department of Clinical Laboratory, Shaoxing University Affiliated Central Hospital, No. 1 Huayu Road, Shaoxing, Zhejiang, 312000, People’s Republic of China, Email rrr0608@163.com Guomei Cao, Department of Clinical Laboratory, Shaoxing University Affiliated Central Hospital, No. 1 Huayu Road, Shaoxing, Zhejiang, 312000, People’s Republic of China, Email caoguomei2021@163.com
Purpose: Pneumocystis jirovecii pneumonia (PCP) is a critical opportunistic infection that predominantly affects immunocompromised patients, particularly those with underlying diseases, and leads to significant morbidity and mortality. This study aimed to enhance the diagnostic accuracy and treatment strategies for PCP by investigating the clinical and laboratory characteristics of patients with suspected PCP and focusing on the diagnostic performance of qPCR and Cycle Threshold (Ct) values.
Patients and Methods: We retrospectively analyzed the clinical and laboratory data of 249 patients at the Central Hospital of Shaoxing University between 2024 and 2025. Clinical characteristics, qPCR test performance, and Ct values were compared between these PCP diagnostic groups, revealing that 8 were classified as definite cases, 32 as probable, and 88 as non-PCP.
Results: The definite group exhibited significantly lower lymphocyte percentages and counts than the probable and non-PCP groups (P =0.003 and P =0.009, respectively). Additionally, beta-d-glucan (BDG) levels were elevated in the definite group (p< 0.001), indicating their potential as reliable biomarkers for PCP diagnosis. The qPCR assay demonstrated high sensitivity (95%) and specificity (99%) in detecting PCP between the PCP and non-PCP groups, with an optimal cut-off Ct value of 35.305 (area under the curve (AUC)=0.98). Correlations among Ct values, lymphocyte percentages, and lactate dehydrogenase (LDH) levels were observed, underscoring the prognostic implications of these laboratory parameters.
Conclusion: Our findings support the integration of qPCR Ct values and BDG in clinical settings to refine the diagnostic criteria and enhance patient management strategies for PCP, paving the way for further research on additional biomarkers and their roles in prognostic assessments.
Keywords: qPCR, cycle threshold Ct values, Pneumocystis jirovecii pneumonia, clinical indicators
Department of Clinical Laboratory, Shaoxing University Affiliated Central Hospital, Shaoxing, Zhejiang, People’s Republic of China
Correspondence: Zhiyong Lu, Department of Clinical Laboratory, Shaoxing University Affiliated Central Hospital, No. 1 Huayu Road, Shaoxing, Zhejiang, 312000, People’s Republic of China, Email rrr0608@163.com Guomei Cao, Department of Clinical Laboratory, Shaoxing University Affiliated Central Hospital, No. 1 Huayu Road, Shaoxing, Zhejiang, 312000, People’s Republic of China, Email caoguomei2021@163.com
Purpose: Pneumocystis jirovecii pneumonia (PCP) is a critical opportunistic infection that predominantly affects immunocompromised patients, particularly those with underlying diseases, and leads to significant morbidity and mortality. This study aimed to enhance the diagnostic accuracy and treatment strategies for PCP by investigating the clinical and laboratory characteristics of patients with suspected PCP and focusing on the diagnostic performance of qPCR and Cycle Threshold (Ct) values.
Patients and Methods: We retrospectively analyzed the clinical and laboratory data of 249 patients at the Central Hospital of Shaoxing University between 2024 and 2025. Clinical characteristics, qPCR test performance, and Ct values were compared between these PCP diagnostic groups, revealing that 8 were classified as definite cases, 32 as probable, and 88 as non-PCP.
Results: The definite group exhibited significantly lower lymphocyte percentages and counts than the probable and non-PCP groups (P =0.003 and P =0.009, respectively). Additionally, beta-d-glucan (BDG) levels were elevated in the definite group (p< 0.001), indicating their potential as reliable biomarkers for PCP diagnosis. The qPCR assay demonstrated high sensitivity (95%) and specificity (99%) in detecting PCP between the PCP and non-PCP groups, with an optimal cut-off Ct value of 35.305 (area under the curve (AUC)=0.98). Correlations among Ct values, lymphocyte percentages, and lactate dehydrogenase (LDH) levels were observed, underscoring the prognostic implications of these laboratory parameters.
Conclusion: Our findings support the integration of qPCR Ct values and BDG in clinical settings to refine the diagnostic criteria and enhance patient management strategies for PCP, paving the way for further research on additional biomarkers and their roles in prognostic assessments.
Keywords: qPCR, cycle threshold Ct values, Pneumocystis jirovecii pneumonia, clinical indicators